Skip to main content

Rhenman & Partners Asset Management AB

Position in BIIB — Biogen Inc.

CIK 1599882 Stockholm, V7

Position in BIIB

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$20,493,291
+$491,988 QoQ
Shares Held
94,850
-13.1% QoQ
Ownership
0.064%
of shares outstanding
% of Portfolio
1.93%
of 13F equity value
Holder Rank
#118
of 1,036 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BIIB Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Rhenman & Partners Asset Management AB holds $173,015,372 across 8 Drug Manufacturers - General names. BIIB ranks #6 (11.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 BIIB
Biogen Inc.
This page
94,850 $20,493,291

All Filings in BIIB

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $20,493,291 94,850
2026-03-31 $20,001,303 109,100
2025-12-31 $16,252,676 92,350
2025-09-30 $7,704,400 55,000
2025-06-30 $1,507,080 12,000
2025-03-31 $6,773,580 49,500
2024-12-31 $18,916,204 123,700
2024-09-30 $13,006,664 67,100
2024-06-30 $19,658,336 84,800
2024-03-31 $12,247,784 56,800
2023-12-31 $15,182,553 58,672
2023-09-30 $14,521,065 56,500
2023-06-30 $18,372,825 64,500
2023-03-31 $13,206,425 47,500
2022-12-31 $8,307,600 30,000
2022-09-30 $8,752,794 32,782
2022-03-31 $3,159,000 15,000
2021-12-31 $27,590,800 115,000
2021-09-30 $42,448,500 150,000
2021-06-30 $31,164,300 90,000
2021-03-31 $5,455,125 19,500
2020-12-31 $9,794,400 40,000
2020-09-30 $9,361,440 33,000
2020-06-30 $4,548,350 17,000
2020-03-31 $7,909,500 25,000